Related Experiment Video
Updated: May 12, 2026

14:53
Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
Published on: June 26, 2020
Injection of neural progenitor cells attenuates decrease in level of connexin 43 in brain capillaries after cerebral
Yoshiyuki Moriyama1, Norio Takagi, Chisa Itokawa
1Department of Molecular and Cellular Pharmacology, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
Neuroscience Letters
|April 16, 2013
Summary
Neural progenitor cells (NPCs) therapy restored connexin 43 (Cx43) levels in brain capillaries after severe cerebral ischemia. This remodeling of the neurovascular unit (NVU) may improve functional outcomes following stroke.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- The neurovascular unit (NVU) plays a critical role in brain function, and its disruption can worsen ischemic injury.
- Changes in gap junctional proteins within the NVU after brain injury are not fully understood.
- Neural progenitor cells (NPCs) show therapeutic potential for post-stroke cognitive and behavioral deficits.
Purpose of the Study:
- To investigate alterations in gap junctional proteins in brain capillaries following severe cerebral ischemia.
- To examine the effect of intravenous NPC injection on these protein levels.
- To explore the potential of NPCs in remodeling the NVU after ischemic stroke.
Main Methods:
- Induction of severe cerebral ischemia using microsphere embolism (ME) in a rat model.
- Isolation and analysis of brain capillaries to assess protein expression.
- Intravenous injection of NPCs or vehicle in ME rats.
- Immunohistochemical analysis to detect connexin 43 (Cx43), aquaporin 4 (AQP-4), and N-cadherin.
Main Results:
- Severe cerebral ischemia led to a sustained decrease in Cx43 and a transient increase in AQP-4 in isolated brain capillaries.
- NPC injection significantly increased Cx43 levels in ME rats compared to vehicle controls.
- Intravenously injected NPCs were observed to migrate into blood vessels in the peri-infarct area.
- NPC treatment did not alter AQP-4 or N-cadherin levels.
Conclusions:
- Severe cerebral ischemia disrupts the astrocyte-endothelial cell interface within the NVU, partly via Cx43 downregulation.
- Intravenous NPC administration can remodel the NVU by restoring Cx43 levels after ischemic injury.
- NPC-mediated NVU remodeling may contribute to functional recovery following cerebral ischemia.

